Of note, the E2F1 transcriptional program is aberrantly activated in the vast majority of human iCCA due to the inactivation of the retinoblastoma protein (pRb) and is sensitive to the treatment with CDK4/6 inhibitors such as Palbociclib [60]. This evidence concerns the gene E2F1 and infantile convulsions and choreoathetosis.